Page last updated: 2024-08-24

valsartan and Cardiomyopathy, Dilated

valsartan has been researched along with Cardiomyopathy, Dilated in 11 studies

Research

Studies (11)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (9.09)	29.6817
2010's	7 (63.64)	24.3611
2020's	3 (27.27)	2.80

Authors

Authors	Studies
Jo, S; Kim, J; Kim, SH; Kwon, YS; Moon, H; Park, K; Sohn, CB	1
Fu, Y; Peng, ML; Ren, H; Wu, CW; Zhang, Y; Zhou, SS	1
Gallinoro, E; Golino, P; Palladino, A; Papa, AA	1
Chen, A; Chen, Z; Dong, Z; Fu, M; Ge, J; Hu, K; Qian, J; Sun, A; Xia, Y; Yang, X; Zou, Y	1
Caivano, M; Gubelli, S	1
Balmforth, C; Jhund, PS; Lefkowitz, M; McMurray, JJV; Packer, M; Rizkala, AR; Rouleau, JL; Shen, L; Shi, V; Simpson, J; Solomon, SD; Swedberg, K; Zile, MR	1
Badole, S; Di Carli, M; Divakaran, S; Eroglu, E; Kijewski, MF; Michel, T; Saravi, SSS; Sorrentino, A; Steinhorn, B; Troncone, L	1
Ahmed, A; Banach, M; Bielecka-Dabrowa, A; Misztal, M; Pietrucha, T; Rysz, J; Sakowicz, A; von Haehling, S	1
Guo, LY; He, Z; Li, JX; Liu, B; Sun, Y; Sun, ZC	1
Altieri, PI; Cangiano, JL; Crespo, MJ; Escobales, N	1
Ma, X; Miao, Y; Sun, H; Tang, MX; Zhang, W; Zhang, Y; Zhong, M	1

Trials

2 trial(s) available for valsartan and Cardiomyopathy, Dilated

Article	Year
Design and rationale for a comparison study of Olmesartan and Valsartan On myocardial metabolism In patients with Dilated cardiomyopathy (OVOID) trial: study protocol for a randomized controlled trial. Trials, 2022, Jan-15, Volume: 23, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Cardiomyopathy, Dilated; Humans; Imidazoles; Middle Aged; Multicenter Studies as Topic; Prospective Studies; Randomized Controlled Trials as Topic; Tetrazoles; Treatment Outcome; Valsartan; Young Adult	2022
Outcomes and Effect of Treatment According to Etiology in HFrEF: An Analysis of PARADIGM-HF. JACC. Heart failure, 2019, Volume: 7, Issue:6 Topics: Aged; Aminobutyrates; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Biphenyl Compounds; Cardiomyopathy, Alcoholic; Cardiomyopathy, Dilated; Cardiotoxicity; Cardiovascular Diseases; Cause of Death; Dangerous Behavior; Diabetic Cardiomyopathies; Drug Combinations; Enalapril; Female; Heart Failure; Heart Valve Diseases; Hospitalization; Humans; Hypertension; Infections; Male; Middle Aged; Mortality; Myocardial Ischemia; Peripartum Period; Stroke Volume; Tetrazoles; Treatment Outcome; Valsartan; Virus Diseases	2019

Article

Year

Design and rationale for a comparison study of Olmesartan and Valsartan On myocardial metabolism In patients with Dilated cardiomyopathy (OVOID) trial: study protocol for a randomized controlled trial.

Trials, 2022, Jan-15, Volume: 23, Issue:1

Topics: Adult; Aged; Aged, 80 and over; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Cardiomyopathy, Dilated; Humans; Imidazoles; Middle Aged; Multicenter Studies as Topic; Prospective Studies; Randomized Controlled Trials as Topic; Tetrazoles; Treatment Outcome; Valsartan; Young Adult

2022

Outcomes and Effect of Treatment According to Etiology in HFrEF: An Analysis of PARADIGM-HF.

JACC. Heart failure, 2019, Volume: 7, Issue:6

Topics: Aged; Aminobutyrates; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Biphenyl Compounds; Cardiomyopathy, Alcoholic; Cardiomyopathy, Dilated; Cardiotoxicity; Cardiovascular Diseases; Cause of Death; Dangerous Behavior; Diabetic Cardiomyopathies; Drug Combinations; Enalapril; Female; Heart Failure; Heart Valve Diseases; Hospitalization; Humans; Hypertension; Infections; Male; Middle Aged; Mortality; Myocardial Ischemia; Peripartum Period; Stroke Volume; Tetrazoles; Treatment Outcome; Valsartan; Virus Diseases

2019

Other Studies

9 other study(ies) available for valsartan and Cardiomyopathy, Dilated

Article	Year
Recovery of complete left bundle branch block in a dilated cardiomyopathy patient after treatment with sacubitril/valsartan: A case report. Medicine, 2022, Jul-08, Volume: 101, Issue:27 Topics: Adult; Aminobutyrates; Angiotensin Receptor Antagonists; Biphenyl Compounds; Bundle-Branch Block; Cardiomyopathy, Dilated; Drug Combinations; Heart Failure; Humans; Male; Stroke Volume; Tetrazoles; Treatment Outcome; Valsartan	2022
Beneficial effects of one-month sacubitril/valsartan treatment in a patient affected by end-stage dystrophinopathic cardiomyopathy. Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology, 2020, Volume: 39, Issue:3 Topics: Activities of Daily Living; Aminobutyrates; Angiotensin Receptor Antagonists; Biphenyl Compounds; Cardiomyopathy, Dilated; Drug Combinations; Drug Monitoring; Dystrophin; Echocardiography; Exercise Tolerance; Heart Failure; Humans; Male; Middle Aged; Muscular Dystrophy, Duchenne; Stroke Volume; Symptom Assessment; Treatment Outcome; Valsartan	2020
LCZ696 improves cardiac function via alleviating Drp1-mediated mitochondrial dysfunction in mice with doxorubicin-induced dilated cardiomyopathy. Journal of molecular and cellular cardiology, 2017, Volume: 108 Topics: Aminobutyrates; Angiotensin Receptor Antagonists; Animals; Apoptosis; Biphenyl Compounds; Cardiomyopathy, Dilated; Cells, Cultured; Disease Models, Animal; Doxorubicin; Drug Combinations; Dynamins; Echocardiography; Female; Gene Expression; Humans; Male; Mice; Mitochondria; Myocytes, Cardiac; Tetrazoles; Valsartan; Ventricular Dysfunction	2017
Case of a patient with heart failure, dilated cardiomyopathy and atrial fibrillation treated with sacubitril/valsartan. Current medical research and opinion, 2019, Volume: 35, Issue:sup3 Topics: Adult; Aminobutyrates; Angiotensin Receptor Antagonists; Atrial Fibrillation; Biphenyl Compounds; Cardiomyopathy, Dilated; Drug Combinations; Heart Failure; Hospitalization; Humans; Male; Stroke Volume; Tetrazoles; Treatment Outcome; Valsartan	2019
Reversal of heart failure in a chemogenetic model of persistent cardiac redox stress. American journal of physiology. Heart and circulatory physiology, 2019, 09-01, Volume: 317, Issue:3 Topics: Aminobutyrates; Angiotensin II Type 1 Receptor Blockers; Animals; Apoptosis; Biphenyl Compounds; Cardiomyopathy, Dilated; D-Amino-Acid Oxidase; Dependovirus; Disease Models, Animal; Drug Combinations; Energy Metabolism; Fungal Proteins; Genetic Vectors; Hydrogen Peroxide; Injections, Intravenous; Male; Mitochondria, Heart; Myocytes, Cardiac; Neprilysin; Oxidative Stress; Promoter Regions, Genetic; Protease Inhibitors; Rats, Wistar; Tetrazoles; Troponin T; Valsartan; Ventricular Function, Left; Ventricular Remodeling	2019
Differences in biochemical and genetic biomarkers in patients with heart failure of various etiologies. International journal of cardiology, 2016, Oct-15, Volume: 221 Topics: Aged; Aminobutyrates; Angiotensin Receptor Antagonists; Biphenyl Compounds; Cardiomyopathy, Dilated; Drug Combinations; Female; Genetic Markers; Genetic Predisposition to Disease; Heart Failure; Humans; Male; Middle Aged; Myocardial Ischemia; Natriuretic Peptide, Brain; Nitric Oxide Synthase Type III; Polymorphism, Single Nucleotide; Stroke Volume; Syndecan-4; Tetrazoles; Transforming Growth Factor beta1; Valsartan	2016
Miraculous Recovery of a Dilated Heart after Usage of Supramaximal Titrated Valsartan for 8 Months. Chinese medical journal, 2016, 11-20, Volume: 129, Issue:22 Topics: Adult; Antihypertensive Agents; Cardiomyopathy, Dilated; Echocardiography; Humans; Male; Valsartan	2016
Aliskiren improves left ventricular dysfunction and reduces cardiac dilation in Syrian cardiomyopathic hamsters. Journal of cardiovascular pharmacology, 2012, Volume: 59, Issue:6 Topics: Amides; Angiotensin II Type 1 Receptor Blockers; Animals; Blood Pressure; Cardiomyopathy, Dilated; Cricetinae; Disease Models, Animal; Disease Progression; Drug Therapy, Combination; Fumarates; Male; Renin; Renin-Angiotensin System; Tetrazoles; Valine; Valsartan; Ventricular Dysfunction, Left	2012
[Effect of valsartan on Tribble 3 gene expression in rats with experimental diabetic cardiomyopathy]. Zhonghua xin xue guan bing za zhi, 2006, Volume: 34, Issue:3 Topics: Animals; Cardiomyopathy, Dilated; Diabetes Mellitus, Experimental; Gene Expression; Male; Protein Kinases; Protein Serine-Threonine Kinases; Rats; Rats, Wistar; RNA, Messenger; Tetrazoles; Valine; Valsartan	2006